Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...

Based on a statement released by Hindenburg Research dated Jan. 15, the firm declared its intention to dissolve after closing its pipeline of cases. The financial investigative company mentioned ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

Empire is based at 40 Wall Street, New York, New York, United States of America. Empire has been engaged for a period of three months, effective February 7, 2025 (the “ Empire Agreement ”). Pursuant ...

The Central Intelligence Agency has assessed that the COVID-19 pandemic is more likely to have emerged from a lab than from nature, an agency spokesperson said on Saturday. The agency had for years ...

ACLF clinical trials expected to initiate in 1Q253 clinical data readouts expected by year-end 2025 across the ACLF pipeline, including on-going UNVEIL-IT® Phase 2 trialData of on-going Phase 1b ...

Unlock the power of scientific thinking to make better decisions in everyday life. Learn how this skill, combined with AI, ...

Unlike short-lived fixes that merely accelerate metabolism for temporary effect, Lipozem takes a root-cause approach, ...

Viehbacher, “Biogen”) announced today an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as treatment for early AD (mild cognitive impairment due to ...

S. Paul Kapur, who previously worked on US-India relations, has been nominated by the Trump administration to lead the South ...

But in the final weeks of the Biden ... in its assessment that a "research-related origin of the COVID-19 pandemic is more likely" and notes in its statement that both scenarios - lab origin ...

Conference call scheduled for 4:30 p.m. ET today Initiation of Phase 3 Studies for Subcutaneous VK2735 for Obesity Planned for 2Q25 Phase 2 VENTURE-Oral Dosing Trial ...